Real-world experience of pembrolizumab in microsatellite instability-high CRC: A Scottish multicenter analysis

被引:4
|
作者
Ghaus, Aisha
Pheely, Ashley
Murdock, Victoria
Shareef, Hala
Samuel, Leslie M.
Clive, Sally
Tough, Fay
Rodgers, Lisa Jane
机构
[1] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[2] Edinburgh Canc Ctr, Edinburgh, Midlothian, Scotland
[3] Aberdeen Royal Infirm, Anchor Unit, Aberdeen, Scotland
[4] Ninewells Hosp, Dundee, Scotland
[5] Aberdeen Royal Infirm, Aberdeen, Scotland
[6] Western Gen Hosp, Edinburgh, Midlothian, Scotland
关键词
D O I
10.1200/JCO.2022.40.4_suppl.054
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
54
引用
收藏
页数:3
相关论文
共 50 条
  • [1] A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis
    Mosalem, Osama
    Tan, Winston
    Bryce, Alan H.
    Dronca, Roxana S.
    Childs, Daniel S.
    Pagliaro, Lance C.
    Orme, Jacob J.
    Kase, Adam M.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 28 (1) : 138 - 144
  • [2] Characteristics of microsatellite instability-high gynecologic cancer and efficacy of pembrolizumab: a single-institution experience
    Taniguchi, Tomoko Sakamoto
    Komiyama, Shinichi
    Nagashima, Masaru
    Morita, Mineto
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (04) : 752 - 756
  • [3] Successful pembrolizumab treatment for microsatellite instability-high thymoma: A case report
    Kaneko, Taichi
    Sekine, Akimasa
    Komatsu, Shigeru
    Otoshi, Ryota
    Haga, Sanshiro
    Tagami, Yoichi
    Kaneko, Takeshi
    Ogura, Takashi
    RESPIRATORY INVESTIGATION, 2024, 62 (04) : 517 - 519
  • [4] Durable response to pembrolizumab in microsatellite instability-high advanced adrenocortical carcinoma
    Senda, Masaya
    Hashimoto, Kohei
    Shindo, Tetsuya
    Kobayashi, Ko
    Tanaka, Toshiaki
    Masumori, Naoya
    IJU CASE REPORTS, 2023, 6 (06) : 382 - 385
  • [5] Clinical and pathological analysis of companion diagnostic testing of microsatellite instability-high for pembrolizumab in gynaecologic malignancy
    Takeda, Takashi
    Tsuji, Kosuke
    Kobayashi, Yusuke
    Banno, Kouji
    Aoki, Daisuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (02) : 128 - 133
  • [6] Predictors of innate resistance to pembrolizumab in patients with microsatellite instability-high endometrial cancer
    How, Jeffrey A.
    Dang, Minghao
    Ferri-Borgogno, Sammy
    Euscher, Elizabeth
    Yates, Melinda S.
    Peng, Weiyi
    Patel, Shrina D.
    Burks, Jared J.
    Vletic, Ivo
    Gomez, Javier
    Lu, Karen
    Mok, Samuel C.
    Wang, Linghua
    Jazaeri, Amir A.
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Successful pembrolizumab treatment of microsatellite instability-high intrahepatic cholangiocarcinoma: A case report
    Ikeda, Yuki
    Ono, Michihiro
    Ohmori, Ginji
    Ameda, Saki
    Yamada, Michiko
    Abe, Tomoyuki
    Fujii, Shigeyuki
    Fujita, Miri
    Maeda, Masahiro
    CLINICAL CASE REPORTS, 2021, 9 (04): : 2259 - 2263
  • [8] Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report
    Katsuya Toshida
    Shinji Itoh
    Tomoharu Yoshizumi
    Tomonari Shimagaki
    Huanlin Wang
    Takeshi Kurihara
    Takeo Toshima
    Yoshihiro Nagao
    Noboru Harada
    Eiji Oki
    Yoshiaki Nakamura
    Takayuki Yoshino
    Masaki Mori
    Clinical Journal of Gastroenterology, 2021, 14 : 1459 - 1463
  • [9] FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
    Marcus, Leigh
    Lemery, Steven J.
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2019, 25 (13) : 3753 - 3758
  • [10] Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report
    Toshida, Katsuya
    Itoh, Shinji
    Yoshizumi, Tomoharu
    Shimagaki, Tomonari
    Wang, Huanlin
    Kurihara, Takeshi
    Toshima, Takeo
    Nagao, Yoshihiro
    Harada, Noboru
    Oki, Eiji
    Nakamura, Yoshiaki
    Yoshino, Takayuki
    Mori, Masaki
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (05) : 1459 - 1463